Literature DB >> 1806168

Adverse reaction to drugs in children, experiences with "spontaneous monitoring" in The Netherlands.

R H Meyboom1.   

Abstract

Drug use may be the cause of a wide variety of different symptoms and disorders in children and many different mechanisms may be involved. A number of situations in childhood may predispose to the development of adverse reactions. In the country-wide "voluntary reporting system" for drug monitoring in the Netherlands, only a small percentage of 4.5 of the case reports concern children (14 years and younger). The reported experiences show that adverse reactions which are important in adults, e.g. blood dyscrasia, erythema multiforme and liver injury, may also be encountered in children. The predominance of physics reactions (e.g. agitation, hallucinations) in suspected relationship with a variety of drugs (sympathicomimetics, anticholinergics, antihistamines, oxolamine) and neurological effects (e.g. dyskinesia in association with metoclopramide or domperidone) suggest that the nervous system in childhood is susceptible to side effects of drugs; further study on this subject seems to be needed. Clinical trials in children are limited because of ethical considerations; as a consequence post-marketing surveillance should pay special attention to this vulnerable group of patients. (Tab. 10, Ref. 23).

Entities:  

Mesh:

Year:  1991        PMID: 1806168

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

Review 1.  Pharmacovigilance in perspective.

Authors:  R H Meyboom; A C Egberts; F W Gribnau; Y A Hekster
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

2.  Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.

Authors:  Kristina Star; G Niklas Norén; Karin Nordin; I Ralph Edwards
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

3.  Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.

Authors:  Lise Aagaard; Camilla Blicher Weber; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

4.  A prospective study of adverse drug reactions in hospitalized children.

Authors:  I Martínez-Mir; M García-López; V Palop; J M Ferrer; E Rubio; F J Morales-Olivas
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 5.  Information about adverse drug reactions reported in children: a qualitative review of empirical studies.

Authors:  Lise Aagaard; Arne Christensen; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

6.  Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.

Authors:  Kevin V Blake; Cosimo Zaccaria; Francois Domergue; Edith La Mache; Agnes Saint-Raymond; Ana Hidalgo-Simon
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.930

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.